Anebulo Pharmaceuticals, Inc. (ANEB): Price and Financial Metrics
ANEB Price/Volume Stats
| Current price | $1.08 | 52-week high | $3.08 |
| Prev. close | $1.13 | 52-week low | $0.80 |
| Day low | $1.08 | Volume | 2,700 |
| Day high | $1.15 | Avg. volume | 21,139 |
| 50-day MA | $1.08 | Dividend yield | N/A |
| 200-day MA | $1.51 | Market Cap | 44.37M |
ANEB Stock Price Chart Interactive Chart >
Anebulo Pharmaceuticals, Inc. (ANEB) Company Bio
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients suffering from cannabinoid overdose and addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.
ANEB Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ANEB Price Returns
| 1-mo | 0.93% |
| 3-mo | 0.93% |
| 6-mo | -30.77% |
| 1-year | -50.23% |
| 3-year | -71.20% |
| 5-year | N/A |
| YTD | -35.71% |
| 2024 | -30.58% |
| 2023 | -0.15% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |